These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26149263)

  • 1. Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.
    Bernstein DI; Bravo FJ; Pullum DA; Shen H; Wang M; Rahman A; Glazer RI; Cardin RD
    Antivir Chem Chemother; 2015 Feb; 24(1):19-27. PubMed ID: 26149263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
    Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
    Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
    Bernstein DI; Ireland J; Bourne N
    Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes.
    Katsumata K; Chono K; Sudo K; Shimizu Y; Kontani T; Suzuki H
    Molecules; 2011 Aug; 16(9):7210-23. PubMed ID: 21869749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models.
    Valencia F; Veselenak RL; Bourne N
    Methods Mol Biol; 2013; 1030():315-26. PubMed ID: 23821278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.
    Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR
    J Virol; 2002 Nov; 76(22):11387-96. PubMed ID: 12388699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Bernstein DI; Morello CS; Cardin RD; Bravo FJ; Kraynyak KA; Spector DH
    Vaccine; 2020 Jan; 38(1):79-89. PubMed ID: 31611098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection.
    Friebe A; Siegling A; Weber O
    J Microbiol Immunol Infect; 2018 Oct; 51(5):587-592. PubMed ID: 28711432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy.
    Farley N; Bernstein DI; Bravo FJ; Earwood J; Sawtell N; Cardin RD
    Antiviral Res; 2010 May; 86(2):188-95. PubMed ID: 20167236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus: the importance of asymptomatic shedding.
    Koelle DM; Wald A
    J Antimicrob Chemother; 2000 Apr; 45 Suppl T3():1-8. PubMed ID: 10855766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
    Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.
    Agyemang E; Magaret AS; Selke S; Johnston C; Corey L; Wald A
    J Infect Dis; 2018 Oct; 218(11):1691-1699. PubMed ID: 30020484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women.
    Strachan E; Saracino M; Selke S; Magaret A; Buchwald D; Wald A
    Brain Behav Immun; 2011 Oct; 25(7):1475-81. PubMed ID: 21693182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
    Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
    JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.
    Jennings R; Smith TL; Myhren F; Phillips J; Sandvold ML
    Antimicrob Agents Chemother; 1999 Jan; 43(1):53-61. PubMed ID: 9869565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
    Schiffer JT; Magaret A; Selke S; Corey L; Wald A
    J Antimicrob Chemother; 2011 Nov; 66(11):2593-600. PubMed ID: 21865349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.